Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BLTE
BLTE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BLTE News
Belite Bio Completes NDA Submission for Tinlarebant
5d ago
Yahoo Finance
Belite Bio Completes NDA Submission for Tinlarebant
5d ago
Newsfilter
Valuation Analysis of Mid-Cap U.S. Healthcare Stocks
Jun 02 2026
seekingalpha
Belite Bio Shares Show Oversold Signal
May 22 2026
NASDAQ.COM
Belite Bio Reports Q1 2026 Earnings with Increased R&D and SG&A Expenses
May 21 2026
Yahoo Finance
Belite Bio Q1 2026 Earnings Call Insights
May 21 2026
seekingalpha
Multiple Companies Set to Report Earnings
May 20 2026
NASDAQ.COM
Belite Bio Reports Q1 Loss and Milestones Update
May 20 2026
NASDAQ.COM
Belite Biopress Q1 Non-GAAP EPS Exceeds Expectations
May 20 2026
seekingalpha
Virtual Investor Conference Presentations Now Available Online
Apr 29 2026
Globenewswire
Deutsche Bank to Host Depositary Receipts Investor Conference
Apr 23 2026
Globenewswire
Belite Bio to Present at Investor Conference
Apr 22 2026
Globenewswire
Belite Bio to Present at Virtual Investor Conference
Apr 22 2026
Newsfilter
Belite Bio Initiates NDA Submission for Tinlarebant to Treat Stargardt Disease
Apr 22 2026
NASDAQ.COM
Insider at Belite Bio (BLTE.US) Plans to Sell $24.31 Million in Common Stock via Form 144
Apr 09 2026
moomoo
Insider at Belite Bio (BLTE.US) Plans to Sell $17.87 Million in Common Stock via Form 144
Apr 09 2026
moomoo
Show More News
